Xencor, Inc.
NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS
Last updated:
Abstract:
The present invention relates to immunoglobulins that bind IgE and Fc.gamma.RIIb with high affinity, said compositions being capable of inhibiting cells that express membrane-anchored IgE. Such compositions are useful for treating IgE-mediated disorders, including allergies and asthma.
Status:
Application
Type:
Utility
Filling date:
5 Feb 2020
Issue date:
22 Oct 2020